Opko Health board authorizes $100M increase to existing share repurchase program

OPKO Health’s (OPK) Board of Directors has authorized an increase of $100M to the Company’s existing common stock repurchase program, bringing the aggregate capacity of the program to $200M. Approximately $41M of OPKO’s common stock has been repurchased under the existing program since its authorization in July 2024.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue